NHS National Framework for Transition products (Nilotinib and Ticagrelor)
NHS England North East and Yorkshire Health and JusticecontractFind a Tender ↗Ref ocds-h6vhtk-04ff90Procurement Act 2023SME suitablepending
Estimated value
—
Awarded value
£22.1m
Awarded 11 Jun 2025
Suppliers
8
4 SME
Lots
1
1 awarded
Published
11 Jul 2025
Other contracts from NHS England North East and Yorkshire Health and Justice· 10
Most recent notices published by the same contracting authority.
Other contracts awarded to ACCORD-UK LTD· 10
Cross-buyer view of this supplier's public-sector wins.
| Title | Type | Value | Published |
|---|---|---|---|
| NHS National Generics Pharmaceuticals - Supply Chain Resilience | contract | — | 01 May 2026 |
| NHS National Branded Interim - 1 June 2026 | contract | — | 16 Apr 2026 |
| NHS Generic Pharmaceuticals - Lenalidomide, Pomalidomide & Thalidomide | contract | — | 26 Mar 2026 |
| Generic Drugs – Injections/Infusions 2 | contract | — | 03 Mar 2026 |
| NHS National Framework for Transition Products (Nintedanib and Dalbavancin) | contract | — | 25 Feb 2026 |
| Transitional Drugs 6 | contract | — | 04 Feb 2026 |
| NHS National Generic Pharmaceuticals - Wave 15c | contract | — | 14 Jan 2026 |
| NHS National Transition Framework for Apremilast, Pazopanib and Dapagliflozin | contract | — | 26 Nov 2025 |
| NHS National Framework for Generics Housekeeping | contract | — | 11 Nov 2025 |
| Project/Contract NHS National Framework for Denosumab Injection | contract | — | 02 Oct 2025 |